Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.
Journal: Journal for immunotherapy of cancer
Published: April 15, 2026
Microsatellite Instability Identifies a Rare but Clinically Relevant Subset of Sarcomas: Insights from the Largest Clinically Sequenced Cohort with Therapeutic Implications.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 13, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma.
Journal: ESMO open
Published: October 29, 2025
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Journal: Cancer research communications
Published: June 25, 2025
Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.
Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 29, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.
Journal: Journal for immunotherapy of cancer
Published: May 28, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.
Journal: ESMO open
Published: May 21, 2025
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 21, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2025
Last Updated: 09/26/2026